Concomitant Medications for Progressive Supranuclear Palsy: A Secondary Analysis of a Randomized Clinical Trial

JAMA Neurol. 2024 Mar 1;81(3):295-297. doi: 10.1001/jamaneurol.2023.5215.
No abstract available

Plain language summary

This secondary analysis of a randomized clinical trial examines changes in the progression of progressive supranuclear palsy (PSP) associated with 31 concomitant medication classes used by study participants over 1 year.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Diagnosis, Differential
  • Disease Progression
  • Humans
  • Supranuclear Palsy, Progressive* / diagnosis
  • Supranuclear Palsy, Progressive* / drug therapy